Cargando…
Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
Immune checkpoint inhibitors (ICIs) have altered the treatment paradigm across a range of tumour types, including gastro-oesophageal cancers. For patients with any cancer type who respond, ICIs can confer long-term disease control and significantly improve survival and quality of life, but for patie...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505606/ https://www.ncbi.nlm.nih.gov/pubmed/34230609 http://dx.doi.org/10.1038/s41416-021-01425-7 |